Response to Therapy Assessment in Intermediate-Risk Differentiated Thyroid Cancer Patients - Is rhTSH Stimulation Required?
Thyroid World Congress ePoster Library. Robenshtok E. 06/21/19; 272132; 55
Eyal Robenshtok
Eyal Robenshtok
Login now to access Regular content available to all registered users.

You may also access this content "anytime, anywhere" with the Free MULTILEARNING App for iOS and Android
Abstract
Rate & Comment (0)

Introduction: The 2015 ATA guidelines recommend response to therapy assessment using rhTSH stimulation 1-2 years following initial treatment in thyroid cancer patients to guide TSH goals and long term follow-up. We hypothesize that data collected during the first year of follow-up may be sufficient to determine response to therapy without Tg-stimulation.



Aim: To determine what is the added value of stimulated-Tg over data collected during the first year of follow-up to predict long-term risk of recurrence/persistence in intermediate-risk patients. 



Methods: Patients treated with total-thyroidectomy and RAI for intermediate-risk DTC, followed for >2 year, who had sufficient follow-up data.

Results: 120 patients met inclusion criteria, with age of 55±15 years. Histology was PTC in 88%, follicular carcinoma in 10% and Hurthle-cell carcinoma in 2%. Follow-up duration was 7±4 years. Based on imaging and stimulated-Tg, 66% had excellent-response to therapy, with long term recurrence rate of 96%. When analyzed without stimulated-Tg, the percentage of patients with early 'excellent response' (ER) was dependent on Tg threshold: with threshold of Tg<1ng/ml, Tg<0.6ng/ml or Tg<0.2ng/ml there was 75%, 58%, and 48% ER rates. Excellent response with threshold of <0.6ng/ml and <0.2ng/ml were equally predictive of long term disease free rates of 96% and 95% respectively. Threshold of <1ng/ml was less predictive with long term disease free rate of 93%.



Conclusions: In patients with no evidence of disease during the first year of follow-up, the addition of stimulated-Tg adds little prognostic information. We suggest a modified definition of excellent response to therapy based on suppressed Tg.

 


Introduction: The 2015 ATA guidelines recommend response to therapy assessment using rhTSH stimulation 1-2 years following initial treatment in thyroid cancer patients to guide TSH goals and long term follow-up. We hypothesize that data collected during the first year of follow-up may be sufficient to determine response to therapy without Tg-stimulation.



Aim: To determine what is the added value of stimulated-Tg over data collected during the first year of follow-up to predict long-term risk of recurrence/persistence in intermediate-risk patients. 



Methods: Patients treated with total-thyroidectomy and RAI for intermediate-risk DTC, followed for >2 year, who had sufficient follow-up data.

Results: 120 patients met inclusion criteria, with age of 55±15 years. Histology was PTC in 88%, follicular carcinoma in 10% and Hurthle-cell carcinoma in 2%. Follow-up duration was 7±4 years. Based on imaging and stimulated-Tg, 66% had excellent-response to therapy, with long term recurrence rate of 96%. When analyzed without stimulated-Tg, the percentage of patients with early 'excellent response' (ER) was dependent on Tg threshold: with threshold of Tg<1ng/ml, Tg<0.6ng/ml or Tg<0.2ng/ml there was 75%, 58%, and 48% ER rates. Excellent response with threshold of <0.6ng/ml and <0.2ng/ml were equally predictive of long term disease free rates of 96% and 95% respectively. Threshold of <1ng/ml was less predictive with long term disease free rate of 93%.



Conclusions: In patients with no evidence of disease during the first year of follow-up, the addition of stimulated-Tg adds little prognostic information. We suggest a modified definition of excellent response to therapy based on suppressed Tg.

 


    This eLearning portal is powered by:
    This eLearning portal is powered by MULTIEPORTAL
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.


Save Settings